Know Your Numbers: 5 Key Labs for Heart Health (a preventive cardiologist's perspective)

When you get bloodwork, it's easy to focus on one number, usually LDL cholesterol. But cardiovascular risk is rarely a single-number story.

In preventive cardiology, I look for a pattern: blood sugar, kidney function, inflammation, and most importantly, the number of cholesterol particles that can enter the artery wall and build plaque.

Here are five high-yield labs I want most adults to know, along with how to interpret them and what to do next.

Key idea: The earlier we identify risk, the easier it is to prevent heart disease, not chase it.

1) CMP (Comprehensive Metabolic Panel)

The CMP is not a "heart test," but it quietly contains several clues about cardiometabolic health.

What it tells us:

• Kidney function (creatinine, eGFR): chronic kidney disease is a major cardiovascular risk enhancer.
• Electrolytes (sodium, potassium, bicarbonate): relevant for blood pressure management, diuretic therapy, arrhythmia risk.
• Liver enzymes (AST/ALT): can hint at metabolic-associated fatty liver disease (MAFLD), which travels with insulin resistance and higher ASCVD risk.
• Glucose (fasting): a piece of the glycemic picture (paired with A1c).

How I use it:

• If kidney function is abnormal, it changes BP goals, medication choices, and overall risk.
• Elevated liver enzymes in the right context may point to metabolic dysfunction and prompt deeper evaluation.

2) Lipid Panel (including non-HDL cholesterol)

Most people know total cholesterol and LDL‑C, but the lipid panel has more to offer.

Key components:

• LDL‑C: cholesterol mass in LDL particles (important, but not the whole story).
• HDL‑C: often called "good cholesterol," but higher isn't always protective; context matters.
• Triglycerides: a marker of insulin resistance and metabolic health, especially when elevated.
• Non‑HDL‑C: total cholesterol minus HDL; captures all atherogenic cholesterol (LDL, remnants, Lp(a), etc.).

Why non‑HDL matters: Non‑HDL is often a better "all‑in" target than LDL‑C alone, particularly when triglycerides are elevated.

3) ApoB (Apolipoprotein B)

If I had to pick one "advanced" lipid marker to add for many patients, it's ApoB.

Why it matters:

• ApoB reflects the number of atherogenic particles (LDL, VLDL, remnants, and Lp(a)).
• Atherosclerosis is driven by particle entry into the artery wall; particle number is the exposure dose.
• ApoB is especially helpful when LDL‑C looks "normal" but risk is not (metabolic syndrome, diabetes, high triglycerides).

Practical interpretation (general targets):

• Lower is better, especially in higher‑risk patients.
• Many guidelines and expert consensus statements support ApoB as a strong risk marker and treatment target, particularly when triglycerides are elevated or discordance is suspected.

4) Lp(a) [Lipoprotein(a)]

Lp(a) is a genetically determined cholesterol particle that increases risk for:

• coronary artery disease
• stroke
• aortic valve stenosis

Two key facts:

• It's largely not changed by lifestyle.
• You typically only need to check it once in a lifetime (unless you're monitoring in special situations).

When I'm especially interested:

• strong family history of premature heart disease
• unexplained early heart disease despite "normal" cholesterol
• recurrent events or high calcium score out of proportion to traditional risk factors

Typical thresholds (lab dependent):

• Many labs flag elevated risk at ≥50 mg/dL or ≥125 nmol/L.

5) hs‑CRP (High-sensitivity C-reactive protein)

hs‑CRP is a marker of systemic inflammation. It's not specific to the heart, but it can help refine risk, especially when you're on the fence.

How I use it:

• Persistent elevation can identify higher inflammatory risk, support intensifying lifestyle/medical therapy, and in select cases influence statin decisions in intermediate‑risk patients.
• It's also a reminder: sleep, stress, visceral fat, periodontal disease, and chronic inflammatory conditions all influence risk.

Important caveat: hs‑CRP rises with infection, injury, and acute illness, so timing matters.

Putting it together: "pattern recognition" in prevention

Here's a simplified way to think about it:

• CMP: organs + metabolic context
• Lipid panel + non‑HDL: baseline lipid risk
• ApoB: particle number (the dose that drives plaque)
• Lp(a): inherited risk you can't lifestyle away
• hs‑CRP: inflammation and residual risk

If you know these numbers, you can have a much higher-quality conversation with your clinician about prevention.

What should you do next?

1. Ask for a copy of your labs and keep them in one place.
2. If you've never checked it, ask about ApoB and Lp(a).
3. Don't interpret labs in isolation; pair them with blood pressure, family history, and (when appropriate) imaging like a coronary calcium score.
4. Use results to guide action: nutrition, activity, sleep, weight, and medications when indicated.

References (IG-friendly)

• Arnett DK, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019.
• Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020.
• Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019.
• Tsimikas S. A test in context: Lipoprotein(a). J Am Coll Cardiol. 2017.
• Ridker PM. C-reactive protein and cardiovascular risk. Circulation. 2003.